This Teleflex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Citigroup analyst Patrick Donnelly downgraded Quest Diagnostics Incorporated DGX from Buy to Neutral and maintained the price target of $185. Quest Diagnostics shares closed at $176.95 on Monday. See how other analysts view this stock.
UBS analyst Manav Gupta downgraded the rating for Green Plains Inc. GPRE from Buy to Neutral and announced a $7 price target. Green Plains shares closed at $5.41 on Monday. See how other analysts view this stock.
Needham analyst Joseph Stringer downgraded Pliant Therapeutics, Inc. PLRX from Buy to Hold and maintained the price target of $10. Pliant Therapeutics shares closed at $1.38 on Monday. See how other analysts view this stock.
B of A Securities analyst Craig Bijou downgraded the rating for Teleflex Incorporated TFX from Neutral to Underperform and lowered the price target from $235 to $140. Teleflex shares closed at $135.13 on Monday. See how other analysts view this stock.
Barclays analyst Ramsey El-Assal downgraded AvidXchange Holdings, Inc AVDX from Overweight to Equal-Weight and lowered the price target from $13 to $8. AvidXchange shares closed at $7.42 on Monday. See how other analysts view this stock.